Table 1.
Demographic and Clinical Data | |
---|---|
Sex | N (%) |
Female | 48 (66.66) |
Male | 24 (33.34) |
Initial age | (SD) |
Total | 76.5 (6.27) |
Female | 76.1 (6.09) |
Male | 77.2 (6.67) |
Residence | N (%) |
Rural | 48 (66.7) |
Urban | 24 (33.3) |
Living arrangement | N (%) |
Alone | 5 (6.9) |
Family | 57 (79.2) |
Institutionalized | 10 (13.9) |
Comorbid vascular diseases | 54 (75.0) |
Psychiatric symptoms | N (%) |
Depression | 47 (65.3) |
Hallucinations and delusion | 14 (19.4) |
Sleep disorders | 15 (20.8) |
Initial treatment dementia | 56 (77.8) |
Psychotropic drugs | 31 (43.1) |
Time of treatment since diagnosis of dementia | 0.57 (1.02) |
Duration of diseasea | 5.04 (2.64) |
Scales | (SD) |
MMSE | 17.31 (4.53) |
GDS | 4.69 (0.70) |
BMI | 27.84 (4.56) |
RDRS-2 | 34.59 (9.10) |
NPIQ-stress | 6.06 (4.82) |
NPIQ-severity | 5.43 (4.03) |
Tinetti global | 21.47 (5.92) |
Gait | 8.62 (3.40) |
Balance | 12.84 (3.11) |
Abbreviations: BMI, body mass index; GDS, Global Deterioration Scale of Reisberg; MMSE, Mini Mental State Examination; N, number; NPIQ, Neuropsychiatric Inventory Questionnaire; RDRS, Rapid Disability Rating Scale; SD, standard deviation; , mean score.
ayears.